Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 4 studies | 21% ± 6% | |
glutamatergic neuron | 4 studies | 31% ± 11% | |
GABAergic neuron | 3 studies | 25% ± 7% | |
neuron | 3 studies | 18% ± 1% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 23% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 757.65 | 1445 / 1445 | 100% | 21.94 | 183 / 183 |
ovary | 100% | 1040.76 | 180 / 180 | 100% | 33.97 | 430 / 430 |
skin | 100% | 965.09 | 1809 / 1809 | 100% | 22.38 | 472 / 472 |
thymus | 100% | 1044.49 | 653 / 653 | 100% | 29.62 | 605 / 605 |
uterus | 100% | 1355.98 | 170 / 170 | 100% | 32.69 | 459 / 459 |
brain | 100% | 652.21 | 2639 / 2642 | 100% | 20.14 | 705 / 705 |
lung | 100% | 868.56 | 578 / 578 | 100% | 21.81 | 1152 / 1155 |
stomach | 100% | 619.52 | 359 / 359 | 100% | 17.86 | 285 / 286 |
intestine | 100% | 822.19 | 966 / 966 | 100% | 19.08 | 525 / 527 |
prostate | 100% | 974.76 | 245 / 245 | 100% | 16.25 | 500 / 502 |
bladder | 100% | 1005.10 | 21 / 21 | 99% | 24.69 | 501 / 504 |
pancreas | 99% | 384.20 | 326 / 328 | 100% | 19.11 | 178 / 178 |
breast | 100% | 923.23 | 459 / 459 | 99% | 18.93 | 1109 / 1118 |
liver | 100% | 564.39 | 226 / 226 | 99% | 11.29 | 402 / 406 |
adrenal gland | 100% | 690.91 | 258 / 258 | 98% | 13.26 | 226 / 230 |
kidney | 100% | 688.89 | 89 / 89 | 98% | 13.55 | 883 / 901 |
adipose | 100% | 947.52 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 26.42 | 29 / 29 |
spleen | 100% | 962.28 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 28.74 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 16.19 | 1 / 1 |
blood vessel | 100% | 876.82 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 448.15 | 854 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 20.03 | 79 / 80 |
muscle | 98% | 438.81 | 790 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 655.57 | 906 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0008150 | Biological process | biological_process |
GO_0016020 | Cellular component | membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
Gene name | TMEM39B |
Protein name | Transmembrane protein 39B |
Synonyms | hCG_41622 |
Description | FUNCTION: May protect the cells against DNA damage caused by exposure to the cold-warming stress and facilitates tissue damage repair during the recovery phase. . FUNCTION: May protect the cells against DNA damage caused by exposure to the cold-warming stress and facilitates tissue damage repair during the recovery phase. . FUNCTION: May protect the cells against DNA damage caused by exposure to the cold-warming stress and facilitates tissue damage repair during the recovery phase. . FUNCTION: May protect the cells against DNA damage caused by exposure to the cold-warming stress and facilitates tissue damage repair during the recovery phase. . FUNCTION: May protect the cells against DNA damage caused by exposure to the cold-warming stress and facilitates tissue damage repair during the recovery phase. . |
Accessions | ENST00000438825.5 Q9NW51 Q5VVU5 Q9GZU3 Q9BT39 ENST00000336294.10 [Q9GZU3-1] F8WB89 ENST00000441402.5 |